ATOMOXETINE SANDOZ kõvakapsel Estland - estisk - Ravimiamet

atomoxetine sandoz kõvakapsel

sandoz pharmaceuticals d.d. - atomoksetiin - kõvakapsel - 10mg 7tk; 10mg 56tk; 10mg 14tk; 10mg 84tk; 10mg 28tk

ATOMOXETINE SANDOZ kõvakapsel Estland - estisk - Ravimiamet

atomoxetine sandoz kõvakapsel

sandoz pharmaceuticals d.d. - atomoksetiin - kõvakapsel - 100mg 56tk; 100mg 28tk; 100mg 14tk

ATOMOXETINE SANDOZ kõvakapsel Estland - estisk - Ravimiamet

atomoxetine sandoz kõvakapsel

sandoz pharmaceuticals d.d. - atomoksetiin - kõvakapsel - 60mg 14tk; 60mg 7tk; 60mg 56tk; 60mg 28tk

ATOMOXETINE SANDOZ kõvakapsel Estland - estisk - Ravimiamet

atomoxetine sandoz kõvakapsel

sandoz pharmaceuticals d.d. - atomoksetiin - kõvakapsel - 80mg 7tk; 80mg 84tk; 80mg 56tk; 80mg 28tk; 80mg 14tk

ATOMOXETINE SANDOZ kõvakapsel Estland - estisk - Ravimiamet

atomoxetine sandoz kõvakapsel

sandoz pharmaceuticals d.d. - atomoksetiin - kõvakapsel - 25mg 56tk; 25mg 84tk; 25mg 14tk; 25mg 7tk

ATOMOXETINE SANDOZ kõvakapsel Estland - estisk - Ravimiamet

atomoxetine sandoz kõvakapsel

sandoz pharmaceuticals d.d. - atomoksetiin - kõvakapsel - 40mg 28tk; 40mg 56tk; 40mg 7tk; 40mg 84tk; 40mg 14tk

ATOMOXETINE SANDOZ kõvakapsel Estland - estisk - Ravimiamet

atomoxetine sandoz kõvakapsel

sandoz pharmaceuticals d.d. - atomoksetiin - kõvakapsel - 18mg 7tk; 18mg 14tk; 18mg 84tk; 18mg 28tk

Zenalpha Den europeiske union - estisk - EMA (European Medicines Agency)

zenalpha

vetcare oy - medetomidine hydrochloride, vatinoxan hydrochloride - psühhoeptikumid, uinutid ja rahustid - koerad - to provide restraint, sedation and analgesia during conduct of non-invasive, non-painful or mildly painful procedures and examinations intended to last no more than 30 minutes.

ATOMOXETIN-NEURAXPHARM kõvakapsel Estland - estisk - Ravimiamet

atomoxetin-neuraxpharm kõvakapsel

pharmathen international s.a. - atomoksetiin - kõvakapsel - 25mg 56tk

Fintepla Den europeiske union - estisk - EMA (European Medicines Agency)

fintepla

ucb pharma s.a.   - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptics, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.